Leidos price target drops to $47: 5 things to know

Citigroup research analysts have cut their price target on Leidos stock from $49 to $47, according to a report by The Legacy. Here are five things to know about the company's shares.

1. Citigroup currently has a "buy" rating on Leidos stock.

2. Leidos stock has a 52-week low of $31.76 and a 52-week high of $47.18.

3. The stock has a 50-day moving average of $41, according to the report. The stock's 200-day moving average is $42.

4. Leidos has a market cap of $3.03 billion.

5. Jefferies Group set the company's price target at $42. Credit Suisse set the price target at $41.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars